SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-029638
Filing Date
2015-05-12
Accepted
2015-05-12 13:24:13
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v409890_10q.htm 10-Q 350993
2 EXHIBIT 31.1 v409890_ex31-1.htm EX-31.1 8776
3 EXHIBIT 31.2 v409890_ex31-2.htm EX-31.2 8788
4 EXHIBIT 32.1 v409890_ex32-1.htm EX-32.1 4431
  Complete submission text file 0001144204-15-029638.txt   3606560

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cltx-20150331.xml EX-101.INS 537261
6 XBRL TAXONOMY EXTENSION SCHEMA cltx-20150331.xsd EX-101.SCH 32102
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cltx-20150331_cal.xml EX-101.CAL 21637
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cltx-20150331_def.xml EX-101.DEF 171803
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cltx-20150331_lab.xml EX-101.LAB 200484
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cltx-20150331_pre.xml EX-101.PRE 198486
Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036
Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804
Celsus Therapeutics Plc. (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 10-Q | Act: 34 | File No.: 001-36288 | Film No.: 15853691
SIC: 2834 Pharmaceutical Preparations